Source: Annual Congress 2002 - Thoracic oncology: biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Toma, G. Tassi, M. Maio, L. Mutti (Genoa, Italy). Synergistic effects of anti-her-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines. Eur Respir J 2002; 20: Suppl. 38, 143

Member's Comments

No comment yet.

Related content which might interest you: Effects of Cisplatin and Pemetrexed on the cell viability and cell adhesion of benign mesothelial and mesothelioma cells. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Relationship between mutated P53 and the acquired multi-drug resistance after cisplatin selection in NCI-H460 cell line of human large cell lung cancer Source: Annual Congress 2004 - Molecular biology Year: 2004 Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549 Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 Inhibitory effects of shRNA targeting twist on epithelial-mesenchymal transition and invasion ability of human lung carcinoma cell A549 in vitro Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006 The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 Functional consequences of cathepsin L-deficiency in the human lung carcinoma cell line A549 Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 The effects of TNF-α combined with VP16 on growth and cell cycle of lung cancer cell line and the adhesive molecules Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002 Expression of RASGRF2 in non-small cell lung cancer and its effect of transfection on biological behavior of human NSCLC lines H1299 Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung carcinoma cell A549 induced by hyaluronan in vitro Source: Eur Respir J 2006; 28: Suppl. 50, 855s Year: 2006 Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Deguelin enhances chemosensitivity of non-small cell lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 336s Year: 2006 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Association of antiPD1 immunotherapy with immunogenic cell death-inducing chemotherapy in a murine model of squamous cell lung cancer Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Effective LncRNAs on myofibroblast differentiation in human A549 cell line treated with TGF-ß Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 The therapeutic efficacy of troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007